Document is current
Any future updates will be listed below
-
Authors
Goede, Lukas L. https://orcid.org/0000-0001-6026-185X
Al-Fatly, Bassam https://orcid.org/0000-0003-0067-6177
Li, Ningfei https://orcid.org/0000-0003-3315-3591
Sobesky, Leon K.
Bahners, Bahne H. https://orcid.org/0000-0003-1963-9798
Zvarova, Patricia https://orcid.org/0009-0004-7831-8796
Neudorfer, Clemens https://orcid.org/0000-0002-3153-1045
Reich, Martin https://orcid.org/0000-0001-9115-5136
Volkmann, Jens https://orcid.org/0000-0002-9570-593X
Zhang, Chencheng https://orcid.org/0000-0003-4472-4134
Odekerken, Vincent J. J.
de Bie, Rob M. A. https://orcid.org/0000-0001-5267-0784
Younger, Ellen F. P.
Corp, Daniel T.
Middlebrooks, Erik H.
Joutsa, Juho https://orcid.org/0000-0002-3457-9415
Dirkx, Michiel https://orcid.org/0000-0001-8763-8071
Deuschl, Günther
Helmich, Rick C.
Kühn, Andrea A. https://orcid.org/0000-0002-4134-9060
Fox, Michael D. https://orcid.org/0000-0001-8848-6399
Horn, Andreas https://orcid.org/0000-0002-0695-6025
-
Funding
Funding for this research was provided by:
Parkinson Fellowship of the Thiemann Foundation
- License Information
-
More Information
Article History
Received: 9 October 2024
Accepted: 13 May 2025
First Online: 22 May 2025
Competing interests
: A.H. reports lecture fees for Boston Scientific, is a consultant for Modulight.bio, was a consultant for FxNeuromodulation and Abbott in recent years and serves as a co-inventor on a patent granted to Charité University Medicine Berlin that covers multisymptom DBS fiberfiltering and an automated DBS parameter suggestion algorithm (patent #LU103178) unrelated to present work. M.D.F. has intellectual property on the use of brain connectivity imaging to analyze lesions and guide brain stimulation; is a consultant for Magnus Medical, Soterix, Abbott, and Boston Scientific; and has received research funding from Neuronetics unrelated to present work. J.J. received congress travel support from Insightec, Abbott, and AbbVie; lecturer honoraria from Addiktum, Insightec, Nordic Infucare, Lundbeck, and Novartis; and consultancy fees from Adamant Health, Summaryx, and TEVA Finland; and owns stock of Neurologic Finland and Suomen Neurolaboratorio and acts as an advisory board member for TEVA Finland unrelated to present work. A.A.K. reports lecturer honoraria and consultancies from Boston Scientific and Medtronic unrelated to present work. The remaining authors declare no competing interests.
